Assisi, Alessandroa; Banzi, Ritaa; Buonocore, Carmelaa; Capasso, Filippoa; Muzio, Valeria Dia; Michelacci, Francescaa; Renzo, Danilaa; Tafuri, Giovannia; Trotta, Francescoa; Vitocolonna, Mariaa; Garattini, Silviob
aDrug Evaluation School Fellow, Regulatory Policies Laboratory, ”Mario Negri” Institute for Pharmacological Research, Milan, Italy
bDirector of ”Mario Negri” Institute for Pharmacological Research, Milan, Italy
Correspondence and requests for reprints to Professor Silvio Garattini, ‘Mario Negri’ Institute for Pharmacological Research, Via Eritrea 62, 20157, Milan, Italy
Tel: +39 02 39014312; fax: +39 02 3546277; e-mail: [email protected]
Authors are listed in alphabetical order and equally contributed to this work.
Conflict of interest statement: None of the authors have any financial or personal relationships with other people or organizations that could be considered conflicts of interest for the present work.
Received 28 March 2006 Accepted 14 August 2006
doi: 10.1097/01.yic.0000224790.98534.11